The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Development of an ethidium monoazide–enhanced internally controlled universal 16S rDNA real‐time polymerase chain reaction assay for detection of bacterial contamination in platelet concentrates
From the National Transfusion Microbiology Laboratories, NHS Blood and Transplant, Colindale; the Research Department of Infection, Division of Infection and Immunity, University College London; and the Blood Borne Virus Unit, Viral Reference Department, Centre for Infections, Health Protection Agency, Colindale, London, UK.
From the National Transfusion Microbiology Laboratories, NHS Blood and Transplant, Colindale; the Research Department of Infection, Division of Infection and Immunity, University College London; and the Blood Borne Virus Unit, Viral Reference Department, Centre for Infections, Health Protection Agency, Colindale, London, UK.
From the National Transfusion Microbiology Laboratories, NHS Blood and Transplant, Colindale; the Research Department of Infection, Division of Infection and Immunity, University College London; and the Blood Borne Virus Unit, Viral Reference Department, Centre for Infections, Health Protection Agency, Colindale, London, UK.
From the National Transfusion Microbiology Laboratories, NHS Blood and Transplant, Colindale; the Research Department of Infection, Division of Infection and Immunity, University College London; and the Blood Borne Virus Unit, Viral Reference Department, Centre for Infections, Health Protection Agency, Colindale, London, UK.
From the National Transfusion Microbiology Laboratories, NHS Blood and Transplant, Colindale; the Research Department of Infection, Division of Infection and Immunity, University College London; and the Blood Borne Virus Unit, Viral Reference Department, Centre for Infections, Health Protection Agency, Colindale, London, UK.
From the National Transfusion Microbiology Laboratories, NHS Blood and Transplant, Colindale; the Research Department of Infection, Division of Infection and Immunity, University College London; and the Blood Borne Virus Unit, Viral Reference Department, Centre for Infections, Health Protection Agency, Colindale, London, UK.
From the National Transfusion Microbiology Laboratories, NHS Blood and Transplant, Colindale; the Research Department of Infection, Division of Infection and Immunity, University College London; and the Blood Borne Virus Unit, Viral Reference Department, Centre for Infections, Health Protection Agency, Colindale, London, UK.
From the National Transfusion Microbiology Laboratories, NHS Blood and Transplant, Colindale; the Research Department of Infection, Division of Infection and Immunity, University College London; and the Blood Borne Virus Unit, Viral Reference Department, Centre for Infections, Health Protection Agency, Colindale, London, UK.